ABOUT

The Asian Society of Neuro-Oncology (ASNO) is a multi-disciplinary organization dedicated to promoting advances in Neuro-oncology through research and education. Every winter, over 400 neurosurgeons and medical professionals from 10 member-countries gather, and together with invited guests from around the globe, we share our knowledge and experience, engage in spirited discussion to refine our ideas, and enjoy the hospitality of friends. This year, ASNO 2019, the 16th annual meeting of the Asian Society for Neuro-oncology, will be held from September 27 to 29, 2019 in Taipei, Taiwan. We eagerly await esteemed members’ productive participation.

 

Theme: Advance in neuro-oncology and clinical treatments
Categories:
  • Brain Tumor - Clinical Research (Including surgery/ Medical treatment/ Radiation/ Clinical trial/ Pathology
  • Brain Tumor - Basic Research (Including experimental/ Immune/ Medical engineering/ AI
  • Nursing/ Paramedical Care/ Secondary Data Analysis
  • Spincal Tumor
  • Pediatric Tumor

Important Dates

  • Abstract Submission Closes
    June 14, 2019
  • Late-Breaking Abstracts Closes
    July 31, 2019
  • Notification of Abstract Review Results
    July 31, 2019
  • Early-bird Registration Closes
    July 31, 2019
  • Last Day for Cancellation of Registration with 75% Refund
    August 25, 2019
  • On-line Registration Closes
    September 8, 2019

Sign in / Sign up

Speaker

  • Keynote Speaker

    Speakers order is based on alphabet order A-Z

  •  

    Invited Speaker


    • Eng-Siew Koh
      University of New South Wales, Australia

    • Zhongping Chen
      Sun Yat-sen University Cancer Center, China

    • Jinsong Wu
      Fudan University, China

    • Tao Jiang
      Beijing Tiantan Hospital, China

    • Chuanlu Jiang
      Harbin Medical University, China

    • Xiangen Shi
      Beijing Sanbo Brain Hospital Capital Medical  University, China

    • Cheng Yang
      Shanghai Changzheng Hospital, China

    • Ho-Keung Ng
      The Chinese University of Hong Kong, HK

    • Wai Sang Poon
      The Chinese University of Hong Kong, HK

    • William Ho Cheung Li
      University of Hong Kong, HK

    • Rakesh Rattan Jalali
      Apollo Proton Cancer Centre, India

    • Rusdy Ghazali Malueka
      Dr Sardjito General Hospital, Indonesia

    • Akitake Mukasa
      Kumamoto University, Japan

    • Fumio Yamaguchi
      Nippon Medical School, Japan

    • Hideki Murakami
      Nagoya City University, Japan

    • Koichi Ichimura
      National Cancer Center Research Institute, Japan

    • Mitsutoshi Nakada
      Kanazawa University, Japan

    • Motoo Nagane
      Kyorin University, Japan

    • Ryuta Saito
      Hokkaido University, Japan

    • Shinya Tanaka
      Tohoku University Hospital, Japan

    • Shozo Yamada
      Moriyama Neurological Center Hospital, Japan

    • Kaoru Kurisu
      Hiroshima University, Japan

    • Takashi Komori
      Tokyo Metropolitan Neurological Hospital, Japan

    • Se-Hyuk Kim
      Ajou University, Korea

    • Yong-Kil Hong
      The Catholic University of Korea, Korea

    • Julette Batara
      University of the Philippines, Philippines

    • Vincent Nga
      National University Cancer Institute, Singapore

    • Chen-Kan Tseng
      Chang Gung Memorial Hospital, Taiwan

    • Der Yang Cho
      China Medical University, Taiwan

    • Diego Shih-Chieh Lin
      Taipei Veterans General Hospital, Taiwan

    • Tai Tong Wong
      Taipei Medical University Hospital, Taiwan

    • Sith Sathornsumetee
      Mahidol University, Thailand

    • Gordon Li
      Stanford University Medical Center, USA

    • L. Eric Huang
      The University of Utah, USA

    • Yazmin Odia
      Baptist Health South Florida, USA

 

Program

To download the Program at-a-glance　　 　 　

█：International　█：201
  • Day 1 - Sep. 26 Thursday
    13:00-17:00
    Registration
  • Day 2 - Sep. 27 Friday
    08:00-18:00
    Registration
    08:20-08:30
    Opening Remark: Challenge of glioma treatment
    08:30-10:30
    Keynote Speech (I)
    8:30-9:00
    Proton therapy: another option in radiation therapy for CNS tumors
    Chen-kan Tseng
    9:00-9:30
    The times they are a-changin. How molecular pathology changed practice for brain tumor diagnosis?
    Ho-Keung Ng
    9:30-10:00
    Clark C. Chen
    10:00-10:30
    Personalized immunotherapy
    Michael Lim
    10:30-10:50
    Coffee Break
    10:50-12:20
    Keynote Speech (II)
    10:50-11:20
    Imaging the Glioblastoma Margin
    Stephen J. Price
    11:20-11:50
    Update on non-surgical treatment for low grade gliomas
    Michael Weller
    11:50-12:20
    Surgery for low grade gliomas: the state of the art (tbd)
    Mitchel S. Berger
    12:20-13:20
    Lunchtime Seminar (I)
    Seizure treatment in glioma (tbd)
    ASNO Business Meeting
    13:20-15:20
    Keynote Speech (III)
    13:20-13:50
    Clinical trials update for low grade glioma
    Patrick Y. Wen
    13:50-14:20
    Enabling Access to Radiosurgery for 2 Million Patients per Year
    John R. Adler
    14:20-14:40
    Molecular Profiling of Gliomas: Implications for Prognosis and Treatment
    Yazmin Odia
    14:40-15:00
    Temozolomide Resistance in Glioblastoma
    Wai Sang Poon
    15:00- 15:20
    Impact of modern high precision photon and proton beam therapy to improve survivorship in brain tumour patients
    Rakesh Rattan Jalali
    13:40-17:10
    Joint Neuropathology Session with Japan Society of Brain Tumor Pathology (JSBTP)
    Advanced and additional image diagnoses for brain tumors and their
    Kaoru Kurisu
    cIMPACT-NOW in an Asian context, beyond WHO2016 Classification of Tumors of CNS
    Takasi Komori
    (Topic Title)
    Diego Shih-Chieh Lin
    The world of Eph/ephrin tyrosine kinase family in glioma
    Mitsutoshi Nakada
    Therapeutic strategies based on temporal and spatial heterogeneity of gliomas
    Akitake Mukasa
    (Topic Title)
    Shinya Tanaka
    15:20-15:35
    Coffee Break
    15:35-17:40
    Spinal tumor session
    15:35-15:40
    Spinal tumor session introduction
    Fon-Yih Tsuang
    15:40-16:10
    Intramedullary spinal tumor treatment
    Guihuai Wang
    16:10-16:40
    Introduction to Primary Spine Tumor Surgery
    Jian Zhao
    16:40-17:10
    Introduction to Metastatic Spine Tumor Surgery
    Cheng Yang
    17:10-17:40
    Surgical Techniques of Total En Bloc Spondylectomy
    Hideki Murakami
    Welcome Reception
  • Day 3 - Sep. 28 Saturday
    07:30-18:00
    Registration
    08:10-08:20
    Opening remark: Role of ASNO in neuro-oncology
    Kuo-Chen Wei
    08:20-08:40
    Collaboration for healthcare improvement
    Honorary Presidents
    08:40-10:10
    Plenary Speech (I)
    8:40-9:10
    The present and future of neurooncology-from neurosurgical aspect?
    Mitchel S. Berger
    9:10-9:40
    Molecular targeted therapy of glioblastoma
    Michael Weller
    9:40-10:10
    Progress of glioma treatment in China
    Tao Jiang
    10:10-10:25
    Coffee Break
    10:25-12:25
    Plenary Speech (II)
    10:25-10:55
    Next generation biomarkers for brain tumor (tbd)
    Wolfgang Wick
    10:55-11:25
    The present and future in the treatment of metastatic brain tumors
    Patrick Y. Wen
    11:25-11:55
    Current state of immunotherapy (tbc)
    Michael Lim
    11:55-12:25
    Recent Progress in Total En Bloc Spondylectomy
    Hideki Murakami
    12:25-13:25
    Lunchtime Seminar (II): Chiu Ho Medical System Company
    　　　　　　
    How we should interpret fluorescence signals for neurosurgery
    Kyousuke Kamada
    13:30-15:15
    Expert Session (I)
    13:30-13:45
    AI Neuropathologists
    Jinsong Wu
    13:45-14:00
    Intraoperative brain mapping by a novel and simple method for the maximal safe resection of tumors
    Fumio Yamaguchi
    14:00-14:15
    (Topic title)
    Vincent Nga
    14:15-14:30
    Prognostic factors in stereotactic radiosurgery for brain metastases
    Se-Hyuk Kim
    14:30-14:45
    Recent Advances in Targeted Therapy For Glioma
    Chuanlu Jiang
    14:45-15:00
    Strategies for MGMT promote unmethylated gliomas
    Zhongping Chen
    15:00-15:15
    (Topic title)
    Eng-Siew Koh
    15:15-15:30
    Coffee Break
    15:30-18:00
    Expert Session (II) & (III)
    15:30-15:45
    Cell Therapy with Dendritic Cells and Chimeric Antigen Receptor T-Lymphocyte and NK Cells (Car-T, Car-NK) for Glioblastoma Multiforme
    Der-Yang Cho
    15:45-16:00
    Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
    Gordon Li
    16:00-16:15
    Is viroimmunotherapy a new hope for malignant gliomas?
    Yong-Kil Hong
    16:15-16:30
    Standard of care and novel therapeutic insights for primary central nervous system lymphoma
    Motto Nagane
    16:30-16:45
    Management and Outcomes of Primary CNS Lymphoma in the Philippines
    Julette Batara
    16:45-17:00
    Treatment of Lower-grade Gliomas: More Evidence but Still Controversial
    Sith Sathornsumetee
    17:00-17:15
    Convection-enhanced Delivery of Nimustine Hydrochloride (ACNU) for Patients With Malignant Glioma
    Ryuta Saito
    17:15-17:30
    Transcranial Surgery with Drilling Tuberculum Sellae/anterior Clinoidotomy for the Resection of Intrasella and Cavernous Sinus Craniopharyngioma in 60 patients
    Xiangen Shi
    17:30-17:45
    Molecular Profiling of Glioma in Indonesia and Its Association with Clinicopathologic Factors
    Rusdy Ghazali Malueka
    17:45-18:00
    The IDH1R132H inhibitor AGI-5198 promotes glioma growth by boosting redox homeostasis
    L. Eric Huang
    13:30-18:00
    Expert Session (IV- Rapid Report) Nursing Session
    Gala Dinner
  • Day 4 - Sep. 29 Sunday
    08:00-12:00
    Registration
    08:10-10:30
    Plenary Speech (III)
    8:10-8:40
    Advances in the diagnosis and treatment of adult gliomas
    Koichi Ichimura
    8:40-9:10
    Endoscopic transnasal approach for the treatment of various types of craniopharyngiomas
    Shozo Yamada
    9:10-9:40
    Management of medulloblastoma in children in the molecular era
    Tai-Tong Wong
    9:40-10:10
    The effectiveness of musical training in reducing depressive symptoms and promoting quality of life among pediatric brain tumor survivors
    William Ho Cheung Li
    10:10-10:30
    Coffee Break
    10:30-10:50
    Plenary Speech (III)
    10:30-10:50
    (topic title)
    Cheng Hong Toh
    10:30-10:50
    Expert Session (Rapid Report)
    10:50-11:20
    Award Presentaion
    11:30-12:50
    Lunchtime Seminar (III)
    Lunchtime Seminar (III)
    13:00-13:05
    Close Remark / Kuo-Chen Wei
    13:05-13:15
    Introduce 2020 / Henry Riyanto Sofyan
    13:30-15:30
    The 9th Taiwan Society for Neuro-oncology Annual Meeting

Location

HNBK International Convention Center

With a variety of venues, first-class hardware facilities and professional conference services, we offer a wide range of venue services from large international conference, concerts, seminars, product launch party and festive banquets.

Address:No.123, Songren Rd., Xinyi Dist., Taipei City 110, Taiwan (R.O.C.)


Transportation

 

My ASNO